Louis C. Bock, Director at Orexigen Therapeutics, Inc. (OREX), bought 27,052 shares at $5.57 ($151K) on 2014-11-12, disclosed to the SEC on 2014-11-13.
Open-market purchase of $151k OREX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |
| ZGNX | BUY | 2010-11-29 | $7.4M | — | Filing → |